Context Therapeutics added to Russell 2000 and Russell 3000 indexes

July 6, 2026 4:07 PM

Context Therapeutics Inc. (Nasdaq: CNTX), a clinical-stage biopharmaceutical company, was added to the Russell 2000 and Russell 3000 indexes ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found